<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131203">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02016677</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-02</org_study_id>
    <nct_id>NCT02016677</nct_id>
  </id_info>
  <brief_title>An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy</brief_title>
  <official_title>An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orbix Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orbix Medical Ltd.</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is  to collect data regarding the aesthetic outcomes of  patients
      who had breast reduction surgery and /or mastopexy in terms such as scaring, patient
      satisfaction, breast ptosis assessment including taking photographs and filling
      questionnaires.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Measuring the aesthetic outcomes of pre /post- surgical breast ptosis</measure>
    <time_frame>during 5 years post- surgically</time_frame>
    <safety_issue>No</safety_issue>
    <description>Breast measurements consists on:
Breast cup size
Distortions or skin retractions
Symmetry between the two breasts
Ptosis grade evaluated on the basis of an I-IV scale
Methods to measure breast shape and symmetry
Skin texture (soft or hard)
Skin consistency
Nipple location on the breast mound scored on a scale of 1 - 5
Areola diameter (mm)
The shape of the breast scored on a scale of 1 - 5
Scar Appearance evaluation -VAS score
Patient satisfaction questionnaires</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Mastopexy</condition>
  <arm_group>
    <arm_group_label>no treatment</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Female Patients, 30 years of age or older referred for elective breast reduction surgery
        and /or mastopxy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female patient older than 30 years of age.

          2. Patients willing to participate as evidenced by signing the written informed consent.

          3. Patient that was found by her physician illegible for breast reduction surgery and
             /or mastopxy

        Exclusion Criteria:

        1. Active psychiatric illness, cognitive or sensory impairment. 2. Physical impairment
        that may prevent filling out a paper and pencil survey or responding to interview
        questions

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arik Zaretski, MD</last_name>
    <role>Study Director</role>
    <affiliation>TASMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arik Zaretski, MD</last_name>
    <phone>03-6973320</phone>
  </overall_contact>
  <location>
    <facility>
      <name>The Plastic Surgery Department The Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arik Zaretski, MD</last_name>
      <phone>03-6973320</phone>
    </contact>
    <investigator>
      <last_name>Arik Zaretski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eyal Gur, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoav Barnea, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 22, 2013</lastchanged_date>
  <firstreceived_date>December 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast reduction</keyword>
  <keyword>Mastopexy</keyword>
  <keyword>sagging</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
